Definition

1. Noun:
   • A post-marketing surveillance study: A "phase IV clinical trial" is a type of study conducted after a drug or treatment has received approval from a regulatory agency (like the FDA) for general public use. Its primary purpose is to monitor the drug's long-term safety, effectiveness, and potential side effects in a broader, more diverse population under real-world conditions.

Usage

• Noun:
  • The new medication's rare side effects were identified during a mandatory phase IV clinical trial.
  • After approval, the company initiated a phase IV clinical trial to gather data on the vaccine's performance across different age groups.

Advanced Usage

• "to enter phase IV": To begin the post-approval monitoring stage.
  • The drug has been successful and will now enter phase IV to monitor long-term outcomes.
• "phase IV study/data/monitoring": Common collocations describing aspects of this trial stage.
  • The phase IV data revealed important information about the drug's interaction with other common medications.

Variants and Related Words

• Post-marketing surveillance (PMS): A nearly synonymous term often used interchangeably with "phase IV clinical trial," emphasizing the monitoring aspect.
• Phase I/II/III clinical trial: The earlier stages of clinical testing that precede phase IV. Phase I tests safety in a small group, Phase II assesses efficacy and side effects, and Phase III confirms effectiveness in large groups for regulatory approval.

Synonyms

• Post-approval study: A study conducted after a drug has been approved for market.
• Post-marketing study: A study focused on monitoring a drug after it has been released for public use.

Related Phrases

• Long-term follow-up: A key component of many phase IV trials, involving tracking patients' health over an extended period.
• Real-world evidence (RWE): The type of data often collected during phase IV trials, from a wider patient population in routine clinical practice, as opposed to the controlled conditions of earlier phases.

Notes

• A defining feature of a phase IV clinical trial is that it often involves a more varied patient population, including individuals with other health conditions or from different demographic groups, who may not have been included in the earlier, more restrictive trial phases. This helps identify rare or long-term adverse effects.

Noun

1. sometimes the FDA approves a drug for general use but requires the manufacturer to continue to monitor its effects; during this phase the drug may be tried on slightly different patient populations than those studied in earlier trials